Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
US8426404B2 · kind B2 · utility
5Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2006 |
| Grant date | Apr 23, 2013 |
| Priority date | — |
| Expiry date | Sep 15, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel class of compounds having Formula Ia,wherein each variable is as defined; and pharmaceutical compositions comprising such compounds and methods of using such compounds for inhibiting c-Src, FGFR3, KDR and/or Lck.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.